Wednesday, February 5, 2020

All day
 
 
Before 01
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
State of the Science for Neurorecovery/Neuroprotection as well as Visual Restoration Products for Retinal Degenerative Conditions
Event Date:

Abstract - Recent FDA cleared/approved devices and biologics as well as current clinical trials in these types of products which promised improved vision by neurorecovery or at least slowing of the vision loss progression with neuroprotection including:  1) Spark Therapeutics LUXTURNA gene therapy; and 2) Okuvision OkuStim Electrical Stimulation Therapy.  In addition, retinal and cortical prosthetics have promised restored vision by substituting mechanisms in the visual system.  This presentation will provide a review of the actual results of these types of products and the challenges that

 
 
 
 
 
 
Have You Heard About the Latest Products for people who have vision loss, FDA Cleared or Not?
Event Date:

Abstract - Dr. Ron Schuchard will review the recent research and development for products that are marketed for treatment of vision loss. This review draws from his experiences as a vision rehabilitation researcher and as a FDA senior staff member.  Attendees will also be encouraged to ask about treatments for vision loss that are of interest to them.